Ingenious Med Ranked a Fastest Growing Company in North America on Deloitte’s 2016 Technology Fast 500™

Atlanta, Georgia – November 29, 2016 – Ingenious Med, developer of the nation’s leading point-of-care solution for aligning physicians and their care teams, today announced its inclusion on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in North America.

“Being one of the fastest growing technology companies in North America for a second straight year is by itself a tremendous accomplishment, especially given our size; being one of fewer than 30 health care technology companies within the Software category, and the only health care technology company in Georgia to make the Deloitte Tech Fast 500 list, evidences the robust adoption of our solutions by health care professionals,” said Joe Marabito, chief executive officer of Ingenious Med. “In just the past 12 months, the number of Ingenious Med users has increased by more than 50%.  I attribute our success to two simple principles: listening to our customers to truly understand the challenges they face in their journey from fee-for-service to value-based care, and designing solutions that better enable physicians to deliver high quality care with less paperwork and hassle.”

“Today, when every organization can be a tech company, the most effective businesses not only foster the courage to explore change, but also encourage creativity in using and applying existing assets in new ways, as resourcefully as possible,” said Sandra Shirai, principal, Deloitte Consulting LLP and U.S. technology, media and telecommunications industry leader. “This ingenious approach to innovation calls for the encouragement of curiosity and collaboration both within and outside the office walls.”

“This year’s Fast 500 winners showcase that when organizations are open to diverse perspectives and insights, they are able to create an environment for their employees and customers to see the possibilities and ingenious solutions that might lie ahead,” added Jim Atwell, national managing partner of the emerging growth company practice, Deloitte & Touche LLP. “Entrepreneurial environments foster change and innovation within businesses, and we look forward to watching these companies continue to drive change across all sectors.”

# # #

About Ingenious Med

Ingenious Med is an Inc. 5000 and Deloitte Technology Fast 500™ company that delivers the nation’s leading patient encounter and physician and care team alignment platform, IM1. The largest health care systems in the U.S. utilize IM1 to coordinate care, document encounters, capture charges, and analyze and improve operations. The award-winning, No. 1 in KLAS IM1 automates workflows at the point of care by offering mobile and web applications for physicians, care teams and administrators. By seamlessly integrating into a health system’s electronic records and billing ecosystem, IM1 creates efficiencies that lower costs while improving the quality of care. IM1 is accelerating the industry’s move toward “The Right Side of Healthcaresm.”

Learn more about how you can capture additional revenue, lower costs and improve quality at www.IngeniousMed.com.

About Deloitte’s 2016 Technology Fast 500™

Deloitte’s Technology Fast 500 provides a ranking of the fastest growing technology, media, telecommunications, life sciences and energy tech companies – both public and private – in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2012 to 2015.

In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least $50,000 USD, and current-year operating revenues of at least $5 million USD. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.

As used in this document, “Deloitte” means Deloitte LLP and its subsidiaries. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.